A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : Ang-2

Search Conditions:
Search Keyword : Ang-2
Search Method : Exact match.
Research Area:

Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: Ang-2
Appearance Frequency: 1040 time(s)
Long forms: 11

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
(1006 times)
(155 times)
VEGF (268 times)
Ang-1 (251 times)
VEGFA (44 times)
1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
(14 times)
(3 times)
VEGF (5 times)
IL-6 (2 times)
MDA (2 times)
2012 [Role of Ang-2, Tie-2 and VEGFR-2 in angiogenesis in colorectal carcinoma and their prognostic value].
(8 times)
Complementary Therapies
(2 times)
VEGF (3 times)
Ang-1 (2 times)
ELISA (2 times)
2010 [Expression of angiogenin-2 and VEGF in acute leukemia and its significance].
(4 times)
(2 times)
BBB (3 times)
CNS (2 times)
GBM (2 times)
2020 PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study.
antiangiogenic growth factor angiopoietin-2
(2 times)
(1 time)
Ang-1 (1 time)
bFGF (1 time)
G-CSF (1 time)
2009 Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
angiogenesis genes angiopoeitin-2
(1 time)
Cell Biology
(1 time)
BrDU (1 time)
IL (1 time)
l-NAME (1 time)
2008 Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.
angiogenin, ribonuclease A family, member 2
(1 time)
Clinical Laboratory Techniques
(1 time)
APE (1 time)
HR (1 time)
OR (1 time)
2022 Plasma Angiopoietin-2 as a Promising Biomarker for the Prognosis of Acute Pulmonary Embolism.
angioregulatory growth factor angiopoietin-2
(1 time)
(1 time)
PDAC (1 time)
VEGF-C (1 time)
2011 Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.
(1 time)
(1 time)
DLTs (1 time)
TEAEs (1 time)
2020 First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.
10  pro-angiogenic and pro-inflammatory cytokine angiopoietin-2
(1 time)
Cell Biology
(1 time)
KS (1 time)
KSHV (1 time)
LANA (1 time)
2012 Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells.
11  pro-angiogenic cytokines angiopoietin-2
(1 time)
(1 time)
CI (1 time)
HCC (1 time)
HR (1 time)
2013 Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.